Skip to main
ESTA
ESTA logo

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Holdings Inc is poised for positive growth, driven by anticipated stronger-than-expected sales of its Motiva implants in the U.S. market, coupled with international expansion. The company's management projects an annual revenue growth of over 20% from 2026 to 2028, alongside a transition to cash flow positivity in 2026, primarily fueled by market growth and the success of new products such as Mia and Preservé. The overall outlook suggests that robust revenue growth will enhance margins and cash flow in the forthcoming years.

Bears say

Establishment Labs Holdings Inc is facing a potential decline in revenue growth, with projections falling below 20% primarily due to disappointing sales of its Motiva implants in the United States. Furthermore, the company is at risk from broader economic factors that may negatively impact international sales, as well as concerns about unforeseen complications associated with its products. Additionally, the prospect of a dilutive equity offering further exacerbates the negative outlook, potentially undermining investor confidence and financial stability.

ESTA has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 6 analysts, ESTA has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.